Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration
Clinical trial NCT06547242 · COMPLETED
Trial details
- NCT number
- NCT06547242
- Sponsor
- Berlin-Chemie AG Menarini Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2022-03-22
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.